Ratings by Guggenheim (Yatin Suneja)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/31/2022 Bausch & Lomb Corp. BLCO New Coverage Buy
(N/A)
17.69
(15.85)
-10.4% Details
5/9/2022 BioXcel Therapeutics BTAI Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Phathom Pharmaceuticals PHAT Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
5/5/2022 EyePoint Pharmaceuticals, Inc. EYPT Maintain Buy
(N/A)
 
 
  Details
4/25/2022 Eliem Therapeutics Inc. ELYM Downgrade Neutral
(Buy)
6.51
(3.65)
-43.93% Details
4/7/2022 BioXcel Therapeutics BTAI Maintain Buy
(N/A)
 
 
  Details
3/22/2022 AnaptysBio ANAB Downgrade Neutral
(Buy)
26.50
(23.12)
-12.75% Details
3/2/2022 Phathom Pharmaceuticals PHAT Maintain Buy
(N/A)
 
 
  Details
3/2/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Inflarx NV IFRX Downgrade Neutral
(Buy)
3.01
(0.78)
-74.09% Details
2/22/2022 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
2/1/2022 Vigil Neuroscience Inc VIGL New Coverage Buy
(N/A)
12.90
(2.91)
-77.44% Details
1/19/2022 Zogenix, Inc. ZGNX Downgrade Neutral
(Buy)
15.64
(26.68)
70.59% Details
1/13/2022 Biogen BIIB Downgrade Neutral
(Buy)
225.34
(211.93)
-5.95% Details
12/21/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
27.09
(14.98)
-44.7% Details
11/2/2021 Sage Therapeutics SAGE Upgrade Buy
(Neutral)
42.37
(33.65)
-20.58% Details
11/1/2021 Acadia Pharmaceuticals ACAD Upgrade Buy
(Neutral)
17.95
(14.98)
-16.55% Details
10/29/2021 argenx SE ARGX Upgrade Buy
(Neutral)
279.58
(364.35)
30.32% Details
10/25/2021 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
10/18/2021 Phathom Pharmaceuticals PHAT Maintain Buy
(N/A)
 
 
  Details
10/4/2021 Xenon Pharmaceuticals XENE Maintain Buy
(N/A)
 
 
  Details
9/15/2021 Surrozen Inc. SRZN New Coverage Buy
(N/A)
10.13
(3.43)
-66.14% Details
9/7/2021 Eliem Therapeutics Inc. ELYM New Coverage Buy
(N/A)
27.56
(3.65)
-86.76% Details
8/10/2021 BioXcel Therapeutics BTAI Maintain Buy
(N/A)
 
 
  Details
7/22/2021 Celldex Therapeutics CLDX New Coverage Buy
(N/A)
43.30
(29.35)
-32.22% Details
7/1/2021 Seelos Therapeutics SEEL New Coverage Buy
(N/A)
2.64
(0.66)
-75% Details
6/21/2021 Orphazyme ORPH Downgrade Buy
(Sell)
7.33
(0.87)
-88.13% Details
6/15/2021 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
72.86
(42.37)
-41.85% Details
6/9/2021 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
6/1/2021 Immunovant IMVT Downgrade Neutral
(Buy)
15.16
(4.17)
-72.49% Details
4/23/2021 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
3/18/2021 Phathom Pharmaceuticals PHAT Maintain Buy
(N/A)
 
 
  Details
3/11/2021 Inflarx NV IFRX Upgrade Buy
(N/A)
4.30
(0.78)
-81.86% Details
3/9/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
45.78
(14.98)
-67.28% Details
2/2/2021 Phathom Pharmaceuticals PHAT New Coverage Buy
(N/A)
38.50
(8.59)
-77.69% Details
1/4/2021 Sage Therapeutics SAGE Upgrade Buy
(Neutral)
86.51
(72.86)
-15.78% Details
11/4/2020 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
10/26/2020 Orphazyme ORPH New Coverage Buy
(N/A)
10.07
(0.87)
-91.36% Details
10/14/2020 AnaptysBio ANAB Upgrade Buy
(Neutral)
17.76
(23.12)
30.18% Details
8/18/2020 Principia Biopharma PRNB Downgrade Neutral
(Buy)
99.25
(100.05)
0.81% Details
8/17/2020 BioXcel Therapeutics BTAI Maintain Buy
(N/A)
 
 
  Details
8/17/2020 Arena Pharma ARNA Maintain Buy
(N/A)
 
 
  Details
7/8/2020 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
7/6/2020 Principia Biopharma PRNB New Coverage Buy
(N/A)
56.00
(99.25)
77.23% Details
6/4/2020 BioXcel Therapeutics BTAI New Coverage Buy
(N/A)
45.14
(12.11)
-73.17% Details
5/26/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
4/27/2020 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
4/8/2020 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
29.03
(33.65)
15.91% Details
3/19/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
2/28/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
2/27/2020 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
2/26/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
2/24/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
2/11/2020 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
2/11/2020 Regeneron Pharma REGN Maintain Buy
(N/A)
 
 
  Details
2/7/2020 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
1/27/2020 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
12/16/2019 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
12/16/2019 Acadia Pharmaceuticals ACAD New Coverage Buy
(N/A)
44.34
(14.98)
-66.22% Details
12/16/2019 Relmada Therapeutics Inc RLMD New Coverage Buy
(N/A)
34.14
(19.65)
-42.44% Details
12/5/2019 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/4/2019 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
11/20/2019 Exicure XCUR New Coverage Buy
(N/A)
2.60
(0.13)
-95% Details
11/15/2019 resTORbio Inc. TORC Downgrade Neutral
(Buy)
7.95
(2.28)
-71.32% Details
11/13/2019 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
11/8/2019 AnaptysBio ANAB Downgrade Neutral
(Buy)
36.16
(23.12)
-36.06% Details
11/8/2019 Ra Pharma RARX Downgrade Neutral
(Buy)
46.90
(48.00)
2.35% Details
11/7/2019 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
10/23/2019 Biogen BIIB Upgrade Buy
(Neutral)
281.87
(211.93)
-24.81% Details
10/16/2019 Axsome Therapeutics AXSM New Coverage Buy
(N/A)
20.63
(24.46)
18.57% Details
9/23/2019 Regeneron Pharma REGn Upgrade Buy
(Neutral)
295.87
(612.49)
107.01% Details
9/20/2019 Xenon Pharmaceuticals XENE New Coverage Buy
(N/A)
9.23
(31.00)
235.86% Details
8/8/2019 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
7/30/2019 Neurocrine Bio. NBIX Maintain Neutral
(N/A)
 
 
  Details
6/27/2019 Zogenix, Inc. ZGNX Upgrade Buy
(Neutral)
39.41
(15.64)
-60.31% Details
6/5/2019 Inflarx NV IFRX Downgrade Neutral
(Buy)
37.29
(0.78)
-97.91% Details
6/5/2019 Neurocrine Bio. NBIX New Coverage Neutral
(N/A)
82.16
(98.24)
19.57% Details
6/5/2019 resTORbio Inc. TORC New Coverage Buy
(N/A)
6.97
(7.95)
14.06% Details
5/7/2019 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
4/9/2019 Zogenix, Inc. ZGNX Downgrade Neutral
(Buy)
51.85
(26.68)
-48.54% Details
4/9/2019 Zogenix, Inc. ZGNX Downgrade Neutral
(Buy)
52.00
(39.41)
-24.21% Details
3/22/2019 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
3/21/2019 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
3/20/2019 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
2/22/2019 Inflarx NV IFRX New Coverage Buy
(N/A)
32.78
(37.29)
13.76% Details
2/22/2019 GW Pharma GWPH New Coverage Buy
(N/A)
145.88
(218.96)
50.1% Details
2/22/2019 Global Blood Therapeutics GBT New Coverage Buy
(N/A)
50.55
(31.79)
-37.11% Details
2/22/2019 Agile Therapeutics AGRX New Coverage Buy
(N/A)
0.96
(1.15)
19.79% Details
2/22/2019 AnaptysBio ANAB New Coverage Buy
(N/A)
65.03
(36.16)
-44.39% Details
2/22/2019 Sage Therapeutics SAGE New Coverage Buy
(N/A)
147.66
(33.65)
-77.21% Details
2/22/2019 Zogenix, Inc. ZGNX New Coverage Buy
(N/A)
47.57
(52.00)
9.31% Details
2/22/2019 Alexion Pharmaceuticals ALXN New Coverage Neutral
(N/A)
129.84
(182.01)
40.18% Details
2/22/2019 Biogen BIIB Downgrade Neutral
(Buy)
335.16
(211.93)
-36.77% Details
2/22/2019 Ra Pharma RARX New Coverage Buy
(N/A)
18.54
(46.90)
152.97% Details
2/21/2019 Regeneron Pharma REGN Downgrade Neutral
(Buy)
422.51
(295.87)
-29.97% Details